Home › Funds › Arrowpoint Investment Partners (Singapore) Pte. Ltd. › CRL

Arrowpoint Investment Partners (Singapore) Pte. Ltd. position in CRL

CHARLES RIV LABS INTL INC · Health Care

Arrowpoint Investment Partners (Singapore) Pte. Ltd. reported holding 8,678 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 0.59% of its reported portfolio and ranking #27 among its reported holdings. Arrowpoint Investment Partners (Singapore) Pte. Ltd. has disclosed CRL holdings in 3 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)8.68K sh
Reported value held$2.56M
Portfolio Weight0.59%
First reportedQ1 2025
Last changeNew
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s CRL position evolved

Arrowpoint Investment Partners (Singapore) Pte. Ltd. first disclosed a stake in CRL in Q1 2025 at 745 shares (US$112K). The position peaked in Q3 2026 at 8,678 shares, worth US$2.6M. Across 3 filings, Arrowpoint Investment Partners (Singapore) Pte. Ltd. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 8,678 shares valued at US$2.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 745 $112.14K New
Q4 2025 4.05K $808.49K New
Q3 2026 8.68K $2.56M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 29 other funds we track also report a position in CRL — the largest reported positions include Allspring Global Investments Holdings, LLC (US$436.5M), ARIEL INVESTMENTS, LLC (US$341.6M), EARNEST PARTNERS LLC (US$254.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has Arrowpoint Investment Partners (Singapore) Pte. Ltd. held CRL?

Arrowpoint Investment Partners (Singapore) Pte. Ltd. has disclosed CRL holdings in 3 of the last 7 reported quarters, going back to Q1 2025.

What is Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s current position in CRL?

As of Q3 2026, Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds 8.68K shares of CRL (CHARLES RIV LABS INTL INC), valued at $2.56M, representing 0.59% of its reported portfolio and ranking #27.

Has Arrowpoint Investment Partners (Singapore) Pte. Ltd. been buying or selling CRL?

In the latest 13F filing (Q3 2026), Arrowpoint Investment Partners (Singapore) Pte. Ltd. newly opened its position in CRL. The position peaked in Q3 2026 at 8.68K shares.

Which other funds hold CRL?

Other major institutional holders of CRL include Allspring Global Investments Holdings, LLC, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.